Mounjaro®
Starting from £179.99/mo
Start journey Learn moreWegovy (semaglutide) can reduce the absorption of oral contraceptive pills, particularly in the early weeks of treatment, because it slows how quickly food and medicines move through your digestive system. For most people on a non-oral method such as patches, implants, injections or an IUD, this is not a concern. If you rely on the pill, current UK clinical guidance recommends adding a barrier method for specific windows during treatment — the details matter, and they depend on which medicine you are taking. Wegovy and Mounjaro (tirzepatide) are both prescription-only weight-loss medicines that require clinical assessment before they are prescribed, and any interaction with your contraception is one of the things a prescriber will ask about.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
It's a reasonable worry, and one that doesn't always get answered clearly at the point of prescribing. Semaglutide (the active ingredient in Wegovy) is a GLP-1 receptor agonist. One of the ways it helps with weight loss is by slowing gastric emptying: your stomach holds onto food longer, which extends the feeling of fullness. That same slowing action applies to anything else you swallow, including oral contraceptive tablets.
When a pill spends longer in a slower-moving gut, the window for it to be absorbed shifts. Peak drug levels in your blood can be lower or delayed compared with what the manufacturer designed for. For contraceptive pills, which rely on consistent hormone levels to suppress ovulation reliably, that variability is worth taking seriously. If you want to understand whether Wegovy messes with birth control and what that means day to day, the answer depends partly on the pill formulation and partly on how much your gut motility has changed, something that varies between individuals and tends to be most pronounced in the first weeks of treatment.
The NHS England guidance on weight-management injections specifically recommends that people using oral contraceptives discuss this with their prescriber before starting Wegovy. The practical step for many people will be adding a reliable barrier method (condoms, for instance) during the early weeks and whenever the dose changes.
If you've been reading about tirzepatide (Mounjaro) alongside Wegovy, you may have noticed that the MHRA-backed advice for Mounjaro is more explicit on this point. Women using oral contraceptives are advised to add a non-oral method for the first four weeks of treatment and for four weeks after each dose increase. That instruction is written into the UK prescribing information because tirzepatide's effect on gastric emptying is well-characterised at each dose step.
For semaglutide, the mechanism is the same in principle, even if the formal instruction is framed slightly differently. The NHS medicines page for semaglutide notes that people should talk to their doctor or pharmacist if they take oral contraceptives, and NHS guidance on weight-management injections advises discussing contraception before starting. The underlying logic is consistent: a slower gut means less predictable pill absorption, and a missed or reduced dose of contraceptive hormone carries real consequences.
If you're curious whether you can take Wegovy alongside birth control, the short answer is yes, but with adjustments depending on your method. This is not a reason to avoid Wegovy. It's a reason to have a specific conversation before you start, so your contraceptive plan stays reliable throughout treatment.
The absorption concern only applies to medicines you swallow. Contraceptive methods that bypass the digestive system entirely are unaffected by Wegovy's slowing effect on gastric emptying. These include the subdermal implant (Nexplanon), the hormonal coil (Mirena and similar), copper coils, the contraceptive injection (Depo-Provera), and contraceptive patches and vaginal rings, because those release hormones directly into the bloodstream without passing through the stomach.
If you currently use one of these methods, there is no evidence that starting Wegovy or Mounjaro changes how effective they are. Some people on GLP-1 medicines do report cycle changes (lighter periods is a commonly noted effect, likely related to weight loss itself rather than any direct hormonal interaction) but that's distinct from contraceptive reliability. For anything unexpected with your cycle, it's worth mentioning to your GP.
It's also worth knowing that if you're thinking about switching contraceptive method specifically to start weight-loss treatment, that's a conversation worth having with your GP or a sexual health clinic first, rather than making the change alone. The timing and the transition matter. Our semaglutide overview covers the broader picture of how this medicine works, if that's useful context.
Wegovy and Mounjaro are not recommended during pregnancy, while breastfeeding, or if you are actively trying to conceive. MHRA guidance advises using effective contraception while taking these medicines and for a washout period before attempting to become pregnant. That makes sorting out your contraceptive plan before starting treatment more than a pharmacokinetic footnote, it's an important safety step.
If you're unsure about the timing or which method makes the most sense given your situation, a prescriber at a clinician-led service can work through it with you. Our clinical team, including our lead prescriber, reviews every consultation personally. Contraception is one of the standard areas covered during a Wegovy assessment, so you won't have to remember to raise it, it's part of the process.
One practical note: if you do decide to use a barrier method during the early weeks of treatment, keep it somewhere you'll actually reach for it. A small pack in your handbag, restocked when you pick up your next pen, tends to work better than one tucked away in a drawer. It's also common to notice your energy dipping during early treatment, and if that happens to you, reading about feeling exhausted on Wegovy may help you understand what's going on and what to do about it.
For context on the cost and what private treatment includes, the Wegovy cost overview sets out what a transparent private prescription covers. If you're ready to talk through your specific situation, including your contraceptive method and whether Wegovy is suitable for you, you can speak to our prescribers through a free consultation.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.